Group One Trading, L.P. Gilead Sciences, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $976,322 - $1.11 Million	13,325 New	13,325 $1.08 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $3.39 Million - $3.87 Million	56,958 Added 1322.45%	61,265 $3.78 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $21.7 Million - $24.4 Million	-375,243 Reduced 98.87%	4,307 $266,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $171,153 - $214,473	-2,955 Reduced 0.77%	379,550 $22.6 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $22.5 Million - $25.6 Million	347,229 Added 984.32%	382,505 $27.8 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $59.4 Million - $64.1 Million	-877,726 Reduced 96.14%	35,276 $2.46 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $10.4 Million - $11.3 Million	163,443 Added 21.81%	913,002 $62.9 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $1.08 Million - $1.23 Million	18,022 Added 2.46%	749,559 $48.4 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $41.4 Million - $47.2 Million	731,537 New	731,537 $42.6 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $9.79 Million - $12.5 Million	-156,271 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $1.17 Million - $1.29 Million	-18,998 Reduced 10.84%	156,271 $10.2 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $1.23 Million - $1.36 Million	-19,714 Reduced 10.11%	175,269 $11.1 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $2.06 Million - $2.31 Million	33,282 Added 20.58%	194,983 $13.2 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $1.18 Million - $1.32 Million	18,848 Added 13.19%	161,701 $10.5 Million
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $4.78 Million - $6.24 Million	79,003 Added 123.73%	142,853 $8.94 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $3.4 Million - $3.77 Million	-47,709 Reduced 42.77%	63,850 $4.93 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2.43 Million - $2.84 Million	37,528 Added 50.69%	111,559 $7.9 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $8.72 Million - $10.6 Million	-119,657 Reduced 61.78%	74,031 $5.58 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $7.44 Million - $8.74 Million	104,608 Added 117.43%	193,688 $13.9 Million
Q3 2017 Nov 15, 2017	SELL	$72.11 - $85.47 $8.28 Million - $9.81 Million	-114,776 Reduced 56.3%	89,080 $7.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	203,856	203,856 $14.4 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account